Arlington Partners’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-28
| Closed | -$7.58K | – | 138 |
|
|
2023
Q4 | $7.58K | Sell |
28
-9
| -24% | -$2.44K | ﹤0.01% | 232 |
|
|
2023
Q3 | $9.1K | Sell |
37
-3,008
| -99% | -$740K | ﹤0.01% | 241 |
|
|
2023
Q2 | $924K | Hold |
3,045
| – | – | 0.14% | 66 |
|
|
2023
Q1 | $803K | Buy |
3,045
+909
| +43% | +$240K | 0.11% | 62 |
|
|
2022
Q4 | $513K | Sell |
2,136
-250
| -10% | -$60K | 0.08% | 64 |
|
|
2022
Q3 | $439K | Hold |
2,386
| – | – | 0.18% | 63 |
|
|
2022
Q2 | $401K | Hold |
2,386
| – | – | 0.13% | 77 |
|
|
2022
Q1 | $598K | Sell |
2,386
-13
| -0.5% | -$3.26K | 0.17% | 60 |
|
|
2021
Q4 | $616K | Buy |
2,399
+41
| +2% | +$10.5K | 0.17% | 60 |
|
|
2021
Q3 | $572K | Hold |
2,358
| – | – | 0.16% | 63 |
|
|
2021
Q2 | $487K | Sell |
2,358
-61
| -3% | -$12.6K | 0.17% | 56 |
|
|
2021
Q1 | $456K | Buy |
2,419
+409
| +20% | +$77.1K | 0.17% | 57 |
|
|
2020
Q4 | $331K | Hold |
2,010
| – | – | 0.15% | 56 |
|
|
2020
Q3 | $251K | Hold |
2,010
| – | – | 0.14% | 59 |
|
|
2020
Q2 | $195K | Hold |
2,010
| – | – | 0.11% | 66 |
|
|
2020
Q1 | $181K | Hold |
2,010
| – | – | 0.09% | 77 |
|
|
2019
Q4 | $297K | Hold |
2,010
| – | – | 0.18% | 45 |
|
|
2019
Q3 | $242K | Hold |
2,010
| – | – | 0.15% | 49 |
|
|
2019
Q2 | $272K | Sell |
2,010
-100
| -5% | -$13.5K | 0.12% | 76 |
|
|
2019
Q1 | $275K | Buy |
+2,110
| New | +$275K | 0.2% | 45 |
|